Summary of conclusions
Download
1 / 5

Summary of Conclusions - PowerPoint PPT Presentation


  • 195 Views
  • Updated On :

Summary of Conclusions. Expert Meeting on a High-Level ACT Subsidy January 18-19, 2007. Main Agreements from Day 1. Vital and urgent need to increase access to ACTs to slow growing drug resistance and rising malaria deaths Broad support for a high-level buyer subsidy

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Summary of Conclusions' - ryanadan


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Summary of conclusions l.jpg

Summary of Conclusions

Expert Meeting on a High-Level ACT Subsidy

January 18-19, 2007


Main agreements from day 1 l.jpg
Main Agreements from Day 1

  • Vital andurgent need to increase access to ACTs to slow growing drug resistance and rising malaria deaths

  • Broad support for a high-level buyer subsidy

  • Confidence that the technical issues can be overcome

  • Agreement that the most appropriate partners will be engaged


Many issues were raised yesterday l.jpg
Many issues were raised yesterday

  • Additional health interventions

  • Actors and partners

  • Incentives for suppliers and distributors

  • End-product vs. component subsidy

  • National regulatory issues

  • Formal vs. informal sector

  • Tariffs and taxes

  • Big-bang vs. phased entry

  • End-user prices

  • Patient and provider behavior

  • Product selection and availability

  • Home-based management

  • Drug resistance

  • Data for monitoring

  • Eligibility of producers

  • Compliance

  • Sustainability

  • Accountability

  • Premium vs. non-premium

  • Effective promotion of generic drugs

  • Quality of drugs

  • Local needs

  • Predictability of demand

  • Conditionalities

  • Incentives for innovation

  • Market distortion

  • Demand forecasting

  • Local manufacturing

  • Equity


Two types of issues l.jpg

Subsidy-Design Tasks

Broader Systemic Issues

Two types of issues

  • Estimate required funding commitment and define subsidy levels/ex-factory price

  • Outline facility architecture and management

  • Develop communication strategy to promote uptake of ACTs

  • Plan for the responsible introduction of ACTs (monitoring of resistance, appropriate technical support, operational research, monitoring and evaluation, equity considerations, sustainability concerns)

  • Strengthen policies to promote quality assurance, pre-qualification, compliance and local manufacturing

  • Strengthen integrated national malaria control programs

  • Leverage community based programs and bolster home based management initiatives

  • Refine demand forecasting

  • Rationalize relevant national policies (e.g. taxes and tariffs, OTC access)


Proposed timeline l.jpg
Proposed Timeline

  • A steering committee will be formed

  • Roll-Back Malaria will convene the first meeting of the steering committee

  • Key dates:

    • First draft of report prepared by Dalberg by early March

    • Detailed plan finalized by Dalberg by June

    • Launch meeting in about November (in Sub-Saharan Africa)


ad